Related Experiment Videos
Intellectual outcome in children with maple syrup urine disease
1Division of Biochemical Development and Molecular Diseases, Children's Hospital of Philadelphia, PA 19104-4303.
Abstract:
We report a controlled study of intellectual outcome in 16 children with maple syrup urine disease (MSUD) that compares the outcome of MSUD diagnosed after symptoms became apparent with that of MSUD diagnosed prospectively and in unaffected siblings and parents. The mean IQ (+/- SD) score in the children with classic MSUD was 78 +/- 24; however, there were two discrete groups: one with normal IQ (greater than 84) whose MSUD had been diagnosed at a mean age of 3.5 days and a second group, with IQ below normal, whose MSUD was diagnosed at a mean of 10 days of age. Affected children treated presymptomatically had higher IQ scores than their affected siblings treated when their disease was symptomatic. Multiple regression analysis indicated that the important influences on IQ were age at the time of diagnosis and long-term metabolic control; control at the time of testing also might have affected performance. The mean score of unaffected siblings was 92 +/- 5 and the mean parental IQ was 83 +/- 9. The mean IQ scores of children with variant MSUD, 97 +/- 4, was similar to that of their parents, 103 +/- 6. This study was not longitudinal and thus could not identify subtle developmental learning problems. We conclude that early and meticulous treatment of MSUD can result in intellectually normal children.
Insights
Early diagnosis and treatment of maple syrup urine disease (MSUD) are crucial for intellectual development. Prompt intervention leads to normal IQ scores in children with MSUD, preventing cognitive deficits.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder.
- Untreated MSUD can lead to severe neurological damage and intellectual disability.
Purpose of the Study:
- To investigate the intellectual outcomes of children with MSUD.
- To compare outcomes based on age at diagnosis and treatment initiation.
- To assess the impact of metabolic control on cognitive function.
Main Methods:
- Controlled study of 16 children with MSUD.
- Comparison of intellectual outcomes between prospectively diagnosed and symptomatically diagnosed MSUD patients.
- Analysis of IQ scores in relation to age at diagnosis, metabolic control, and family comparisons.
Main Results:
- Children with classic MSUD diagnosed early (mean age 3.5 days) had normal IQs (mean >84).
- Children diagnosed later (mean age 10 days) had below-normal IQs.
- Presymptomatic treatment correlated with higher IQ scores compared to symptomatic treatment.
- Age at diagnosis and long-term metabolic control significantly influenced IQ.
Conclusions:
- Early and meticulous treatment of MSUD can lead to intellectually normal children.
- Timely diagnosis and sustained metabolic management are key to optimizing cognitive outcomes in MSUD.